CRH is trading at $88.44, up 5.3%, after an unexplained pre-market jump from the September 24 close.

  • No confirmed September 25 company-specific catalyst, earnings release, filing, or acquisition update was identified.
  • Shareholder approval for the Arcosa transaction was reported on September 4; closing is expected in the first quarter of 2027.
  • Broader futures are modestly higher, but the move is too small to clearly explain CRH’s surge.